• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Medical aspects of the multidisciplinary assessment and management of osteoarthritis.

作者信息

Muncie H L

出版信息

Clin Ther. 1986;9 Suppl B:4-13.

PMID:3829096
Abstract

Osteoarthritis, the most common form of arthritis, influences a person's mental well-being, ability to work or perform activities of daily living, and personal and family relationships. Ideally, the management of this disease is multidisciplinary, involving not only the use of medication but also exercise instruction, dietary counseling, and psychosocial interventions. The effects of such a comprehensive treatment program have not been well studied. A 12-week trial of multidisciplinary assessment and management of osteoarthritis was conducted. In addition to receiving the anti-inflammatory agent sulindac, patients were evaluated and followed up by health professionals in the disciplines of medicine, physical therapy, occupational therapy, nutrition, social work, and psychology. An initial assessment of the degree of pain, swelling, tenderness, stiffness, and ability to conduct activities of daily living was made, which represented patients' entry status. Subsequent assessments were made by the multidisciplinary team every two weeks for 12 weeks. Seventy-seven patients completed at least ten of the 12 weeks. On entering the study, two thirds of the patients had pain, tenderness, or swelling affecting the hip, knee, or hand. At the end of 12 weeks, 80% of the patients had improvement in their osteoarthritis, and 71% improved in their ability to conduct activities of daily living. The results support the view that a comprehensive approach to osteoarthritis can significantly reduce disability and pain.

摘要

相似文献

1
Medical aspects of the multidisciplinary assessment and management of osteoarthritis.
Clin Ther. 1986;9 Suppl B:4-13.
2
Occupational therapy in the multidisciplinary assessment and management of osteoarthritis.
Clin Ther. 1986;9 Suppl B:24-9.
3
Psychological evaluation of well-being in the multidisciplinary assessment of osteoarthritis.骨关节炎多学科评估中幸福感的心理评估
Clin Ther. 1986;9 Suppl B:53-63.
4
Physical therapy in the multidisciplinary assessment and management of osteoarthritis.
Clin Ther. 1986;9 Suppl B:14-23.
5
Nutrient intake and obesity in a multidisciplinary assessment of osteoarthritis.
Clin Ther. 1986;9 Suppl B:30-42.
6
Management of osteoarthritis (OA) with an unsupervised home based exercise programme and/or patient administered assessment tools. A cluster randomised controlled trial with a 2x2 factorial design.采用无监督的家庭锻炼计划和/或患者自我管理评估工具对骨关节炎(OA)进行管理。一项采用2×2析因设计的整群随机对照试验。
Ann Rheum Dis. 2004 Jun;63(6):703-8. doi: 10.1136/ard.2003.009803.
7
Psychosocial aspects of the multidisciplinary assessment of osteoarthritis.
Clin Ther. 1986;9 Suppl B:43-52.
8
Effects of aquatic exercise on flexibility, strength and aerobic fitness in adults with osteoarthritis of the hip or knee.水上运动对髋或膝骨关节炎成年人柔韧性、力量和有氧适能的影响。
J Adv Nurs. 2007 Jan;57(2):141-52. doi: 10.1111/j.1365-2648.2006.04102.x.
9
A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.一项为期2周的多中心、随机、双盲、安慰剂对照、剂量范围研究的III期试验,比较了羟考酮缓释剂与安慰剂对患有髋部或膝部骨关节炎相关疼痛的成年人的疗效。
Clin Ther. 2006 Mar;28(3):352-64. doi: 10.1016/j.clinthera.2006.03.008.
10
Osteoarthritis and non-steroidal and anti-inflammatory drugs: a multi-centre comparative study.
Curr Med Res Opin. 1982;7(Suppl 1):41-52.

引用本文的文献

1
Sulindac compounds facilitate the cytotoxicity of β-lapachone by up-regulation of NAD(P)H quinone oxidoreductase in human lung cancer cells.舒林酸化合物通过上调人肺癌细胞中NAD(P)H醌氧化还原酶促进β-拉帕醌的细胞毒性。
PLoS One. 2014 Feb 5;9(2):e88122. doi: 10.1371/journal.pone.0088122. eCollection 2014.